Rocky Mountain spotted fever natural history: Difference between revisions

Jump to navigation Jump to search
Ilan Dock (talk | contribs)
No edit summary
Ilan Dock (talk | contribs)
No edit summary
Line 68: Line 68:


==Prognosis==
==Prognosis==
*Treatment usually cures the [[infection]].  
*The prognosis is usually good for patients suffering from a Rocky Mountain Spotted fever infection.  
*Complications can include [[paralysis]], hearing loss, [[nerve]] damage, and, if left untreated or treated but less commonly occurring, death.  
*Factors that might contribute to a poor prognosis are infections within children 0-9, especially 5-9, and adults over 60 years of age. With a higher rate of fatality within these groups.
*Rocky Mountain spotted fever can be a severe illness, and the majority of patients are hospitalized.  
*Other factors that contribute to a poor prognosis are race and gender. Infections rates are higher among populations of White and Native American males.  
*Prior to the development of [[tetracycline]] and [[chloramphenicol]], [[antibiotics]], Rocky mountain spotted fever's [[mortality rate]] was as high as 87%. Now, with new medical practices including the implementation of antibiotic therapies, the mortality rate is approximately 20% if untreated and 5% if treated properly. <ref name="RMSF DeptImmuno”>  Dantas-Torres, Filipe. Lancet Infect Disease 2007;7:724-32. Department of Immunology, Center of Research Aggeu Magalhaes, Oswaldo Cruz Foundation. Recife Pernambuco, Brazil. Volume 7, November 2007. Accessed on January 11, 2016</ref>
*It should be noted that although the prognosis is usually good, RMSF is a severe illness and many infected patients will be hospitalized.  
*The mortality rate is approximately 20% if untreated and 5% if treated properly. <ref name="RMSF DeptImmuno”>  Dantas-Torres, Filipe. Lancet Infect Disease 2007;7:724-32. Department of Immunology, Center of Research Aggeu Magalhaes, Oswaldo Cruz Foundation. Recife Pernambuco, Brazil. Volume 7, November 2007. Accessed on January 11, 2016</ref>
*Infection with R. rickettsii may provide long lasting [[immunity]] against re-infection.  
*Infection with R. rickettsii may provide long lasting [[immunity]] against re-infection.  
*Previous infection with Rocky Mountain spotted fever should not deter persons from practicing good tick-preventive measures or visiting a [[physician]] if signs and symptoms consistent with Rocky Mountain spotted fever occur, especially following a tick bite, as other diseases may also be transmitted by ticks. <ref name="RMSF ID”>  Rocky Moutnain Spotted Fever. Department of Health. Idaho Health District 4. http://www.cdhd.idaho.gov/CD/public/factsheets/rockymtnspottedfever.htm Accessed on January 11, 2016</ref>
*Previous infection with Rocky Mountain spotted fever should not deter persons from practicing good tick-preventive measures or visiting a [[physician]] if signs and symptoms consistent with Rocky Mountain spotted fever occur, especially following a tick bite, as other diseases may also be transmitted by ticks. <ref name="RMSF ID”>  Rocky Moutnain Spotted Fever. Department of Health. Idaho Health District 4. http://www.cdhd.idaho.gov/CD/public/factsheets/rockymtnspottedfever.htm Accessed on January 11, 2016</ref>


==Illness Severity==
[[Image:RMSF incidence.jpg|left|300px|Epidemiology Graph 3 - Comparison between RMSF cases and their fatality.]]
[[Image:RMSF incidence.jpg|left|300px|Epidemiology Graph 3 - Comparison between RMSF cases and their fatality.]]



Revision as of 15:31, 12 January 2016

Rocky Mountain spotted fever Microchapters

Home

Patient Info

Overview

Historical Perspective

Classification

Pathophysiology

Epidemiology & Demographics

Risk Factors

Causes

Differentiating Rocky Mountain spotted fever from other Diseases

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Laboratory Findings

Chest X-Ray

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Case Studies

Case #1

Rocky Mountain spotted fever natural history On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rocky Mountain spotted fever natural history

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rocky Mountain spotted fever natural history

CDC on Rocky Mountain spotted fever natural history

Rocky Mountain spotted fever natural history in the news

Blogs on Rocky Mountain spotted fever natural history

Directions to Hospitals Treating Rocky Mountain spotted fever

Risk calculators and risk factors for Rocky Mountain spotted fever natural history

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ilan Dock, B.S.

Overview

If left untreated patients with Rocky Mountain Spotted Fever will undergo three developmental stages of infection. The early stages of infection begin within 2-14 days of inoculation by an infected tick and present themselves as a fever, nausea, vomiting, and a severe headache. Late stage progression of symptoms will result in a maculopapular rash, abdominal and joint pain. Further progression of the disease, if left untreated, will result in the following complications; gangrene, pulmonary complications, ARDS, cerebral edema as well as other long term complications. Ultimately, if Rocky Mountain Spotted Fever progresses entirely untreated, it will conclude in the patient's death. With a fatality rate as high as 87%, without antibiotic intervention. [1] [2]

Natural history

Rocky Mountain Spotted fever patients will progress from early symptoms to late symptoms and possible chronic conditions, as well as death, if left untreated. The infection begins with inoculation of the disease from an infected tick. Once inoculated, the organism Rickettsia rickettsii will incubate for 2- 14 days. As the incubation period concludes early onset symptoms will begin, these symptoms are listed below.

Early Onset Symptoms:

Treatment is most effective if an antibiotic therapy is administered at this point. As the disease progresses, treatment loses effectiveness, thus it is of utmost importance to diagnose and begin treatment early on. Most individuals who begin treatment will usually clear the infection.

After the first three days of early onset symptoms, other symptoms will progress. These symptoms are described as late stage symptoms and will include the characteristic rash that is commonly associated with Rocky Mountain Spotted fever. Not all patients will have the same clinical presentation of the disease. Particularly, the rash is present within the majority of infected patients, yet 10-15% of patients may never develop the characteristic spotted rash. If the infection progresses in severity, patients will be hospitalized at this point. Late stage symptoms may be observed below.

Late Stage:

With proper treatment and antibiotic therapy, most patients will have cleared the infection. However, if left untreated or improperly diagnosed, Rocky Mountain Spotted Fever will progress further and may involve chronic complications or severe tissue damage as well as death. Complications and chronic conditions associated with untreated development of Rocky Mountain Spotted fever are found below. Untreated or Improperly Diagnosed:

Complications

Possible complications include:

Long term complications:

  • Paralysis of lower extremities
  • Impaired bladder function
  • Impaired bowel function
  • Amputation
  • Hearing impairment
  • Speech Disorders[3]

Prognosis

  • The prognosis is usually good for patients suffering from a Rocky Mountain Spotted fever infection.
  • Factors that might contribute to a poor prognosis are infections within children 0-9, especially 5-9, and adults over 60 years of age. With a higher rate of fatality within these groups.
  • Other factors that contribute to a poor prognosis are race and gender. Infections rates are higher among populations of White and Native American males.
  • It should be noted that although the prognosis is usually good, RMSF is a severe illness and many infected patients will be hospitalized.
  • The mortality rate is approximately 20% if untreated and 5% if treated properly. [2]
  • Infection with R. rickettsii may provide long lasting immunity against re-infection.
  • Previous infection with Rocky Mountain spotted fever should not deter persons from practicing good tick-preventive measures or visiting a physician if signs and symptoms consistent with Rocky Mountain spotted fever occur, especially following a tick bite, as other diseases may also be transmitted by ticks. [5]
Epidemiology Graph 3 - Comparison between RMSF cases and their fatality.
Epidemiology Graph 3 - Comparison between RMSF cases and their fatality.

Initial health problems

  • Rocky Mountain spotted fever can be a very severe illness and patients often require hospitalization. Because R. rickettsii infects the cells lining blood vessels throughout the body, severe manifestations of this disease may involve the respiratory system, central nervous system, gastrointestinal system, or renal system.
  • Host factors associated with severe or fatal Rocky Mountain spotted fever include advanced age, male sex, African-American race, chronic alcohol abuse, and

glucose-6-phosphate dehydrogenase (G6PD) deficiency.

  • Deficiency of G6PD is a sex-linked genetic condition affecting approximately 12% of the U.S.
  • African-American male population; deficiency of this enzyme is associated with a high proportion of severe cases of Rocky Mountain spotted fever. This is a rare clinical course that is often fatal within 5 days of onset of illness. [6]
  • Long-term health problems following acute Rocky Mountain spotted fever infection include partial paralysis of the lower extremities, gangrene requiring amputation of fingers, toes, or arms or legs, hearing loss, loss of bowel or bladder control, movement disorders, and language disorders.
  • These complications are most frequent in persons recovering from severe, life-threatening disease, often following lengthy hospitalizations. [6]

Long term health problems

References

  1. 1.0 1.1 1.2 Mills, Jackie. Rocky Mountain Spotted Fever. Austin CC. Derived: Masters, E. J., G. S. Olson, S. J. Weiner, and C. D. Paddock. 2003. Rocky Mountain spotted fever: a clinician’s dilemma. Archive of Internal Medicine 163:769–774. http://archinte.ama-assn.org/cgi/content/full/163/7/769 Accessed January 11, 2016
  2. 2.0 2.1 Dantas-Torres, Filipe. Lancet Infect Disease 2007;7:724-32. Department of Immunology, Center of Research Aggeu Magalhaes, Oswaldo Cruz Foundation. Recife Pernambuco, Brazil. Volume 7, November 2007. Accessed on January 11, 2016
  3. 3.0 3.1 Rocky Mountain Spotted Fever general information. American Lyme Disease Foundation (2016). Accessed on January 11, 2016
  4. Rocky Mountain Spotted Fever Symptoms. Centers for Disease Control and Prevention (2015). http://www.cdc.gov/rmsf/symptoms/index.html Accessed on December 30, 2015
  5. Rocky Moutnain Spotted Fever. Department of Health. Idaho Health District 4. http://www.cdhd.idaho.gov/CD/public/factsheets/rockymtnspottedfever.htm Accessed on January 11, 2016
  6. 6.0 6.1 6.2 Rocky Mountain Spotted Fever Symptoms. Centers for Disease Control and Prevention (2015). http://www.cdc.gov/rmsf/symptoms/index.html Accessed on December 30, 2015